To test whether the levels of circulating stem cells expressing the CD133 antigen could predict the clinical severity and progression of DMD, we assessed stem cell levels in DMD patients and analyzed the potential correlation with clinical results. Here, PROM1 is linked to Duchenne muscular dystrophy.